Jang JS - Search Results

1

A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites.

Oh SY, Kwon HC, Lee S, Lee DM, Yoo HS, Kim SH, Jang JS, Kim MC, Jeong JS, Kim HJ. Oh SY, et al. Among authors: jang js. Jpn J Clin Oncol. 2007 Dec;37(12):930-5. doi: 10.1093/jjco/hym131. Jpn J Clin Oncol. 2007. PMID: 18211984 Clinical Trial.

2

Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.

Choi SR, Jang JS, Lee JH, Roh MH, Kim MC, Lee WS, Qureshi W. Choi SR, et al. Among authors: jang js. Dig Dis Sci. 2006 Nov;51(11):2081-6. doi: 10.1007/s10620-006-9166-5. Epub 2006 Sep 29. Dig Dis Sci. 2006. PMID: 17009116

3

[A case of the treatment in an adult with hepatic undifferentiated (embryonal) sarcoma].

Kim KT, Han SY, Park EH, Jang JS, Roh MH, Lee SW, Jeong JS. Kim KT, et al. Among authors: jang js. Korean J Hepatol. 2007 Mar;13(1):96-102. Korean J Hepatol. 2007. PMID: 17380080 Korean.

4

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

Oh SY, Kwon HC, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim CO, Kim SJ, Jeong JS, Kim HJ. Oh SY, et al. Among authors: jang js. BMC Cancer. 2008 May 1;8:123. doi: 10.1186/1471-2407-8-123. BMC Cancer. 2008. PMID: 18452596 Free PMC article.

5

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.

Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, Kim SG, Kim SH, Jang JS, Kim MC, Kim KH, Han JY, Kim HJ. Kim DK, et al. Among authors: jang js. BMC Cancer. 2009 May 20;9:155. doi: 10.1186/1471-2407-9-155. BMC Cancer. 2009. PMID: 19457231 Free PMC article.

6

Early detection of recurrence after endoscopic treatment for early gastric cancer.

Sohn YJ, Jang JS, Choi SR, Kwon HC, Jung GJ, Kim MC, Jeong JS. Sohn YJ, et al. Among authors: jang js. Scand J Gastroenterol. 2009;44(9):1109-14. doi: 10.1080/00365520903121701. Scand J Gastroenterol. 2009. PMID: 19593687

7

Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.

Baek YH, Lee JH, Jang JS, Lee SW, Han JY, Jeong JS, Choi JC, Kim HY, Han SY. Baek YH, et al. Among authors: jang js. Hepatogastroenterology. 2009 May-Jun;56(91-92):763-7. Hepatogastroenterology. 2009. PMID: 19621698

8

[Predictive significance of serum IL-6, VEGF, and CRP in gastric adenoma and mucosal carcinoma before endoscopic submucosal dissection].

Jang JS, Choi SR, Han SY, Roh MH, Lee JH, Lee SW, Jeung JS, Kim MC, Son YK, Baek YH. Jang JS, et al. Korean J Gastroenterol. 2009 Aug;54(2):99-107. doi: 10.4166/kjg.2009.54.2.99. Korean J Gastroenterol. 2009. PMID: 19696537 Free article. Korean.

9

Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection.

Lee SA, Choi SR, Jang JS, Lee JH, Roh MH, Kim SO, Kim MC, Kim SJ, Jeong JS. Lee SA, et al. Among authors: jang js. Dig Dis Sci. 2010 Jul;55(7):1955-63. doi: 10.1007/s10620-009-0967-1. Epub 2009 Sep 12. Dig Dis Sci. 2010. PMID: 19757047

10

A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.

Kim BG, Oh SY, Kwon HC, Lee S, Lee DM, Kim SG, Kim DK, Jang JS, Kim MC, Kim SH, Kim HJ. Kim BG, et al. Among authors: jang js. Am J Clin Oncol. 2010 Jun;33(3):246-50. doi: 10.1097/COC.0b013e3181a650d4. Am J Clin Oncol. 2010. PMID: 19770628 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters